Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Proteomics. 2010 Dec;10(23):4163–4171. doi: 10.1002/pmic.201000229

Table 3.

Odds ratio of optimal codon usage between exposed-aggregation-prone and exposed-non-aggregation-prone sites, between buried-aggregation-prone and buried-non-aggregation-prone sites, between exposed-aggregation-prone and buried-non-aggregation-prone sites, and between buried-aggregation-prone and exposed-non-aggregation-prone sites for each amino acid

E. coli
S. cerevisiae
D. melanogaster
M. musculus
AA EA-EN BA-BN EA-BN BA-EN EA-EN BA-BN EA-BN BA-EN EA-EN BA-BN EA-BN BA-EN EA-EN BA-BN EA-BN BA-EN
Ala 1.02 1.05 1.07 0.93 0.70 0.92 0.57(**) 0.99 1.45(*) 1.08 1.25 1.22
Arg 1.02 1.04 1.06 1.01 1.57 1.13 1.56 0.90 1.31 0.93 1.28 1.22 1.33(*) 1.16 1.26 1.44*
Asn 1.27*(*) 1.02 0.94 1.46*** 0.88 1.12 0.94 1.16 1.17 1.63*(*) 1.28 1.57*(*) 1.14 1.12 0.88 1.41***
Asp 1.15 1.18 1.05 1.22(*) 1.03 0.84 1.10 0.78 1.65*** 1.64*(*) 1.87*** 1.50*(*) 1.11 1.23 1.08 1.30*(*)
Cys 0.78 1.03 1.13 0.83 1.60 0.76 0.29(*) 0.84 0.54 1.03 1.04 0.82
Gln 1.02 0.89 0.84 1.13 1.08 1.14 1.31 1.42 0.75 0.94 0.84 0.91 1.04 1.27 0.98 1.42*(*)
Glu 0.96 1.00 0.90 1.07 1.01 1.35 1.15 1.26 0.91 0.82 0.97 0.91 0.89 1.05 0.83 1.05
Gly 1.24(*) 1.31**(*) 1.19 1.37*** 0.94 0.94 0.70(*) 1.32(*) 0.92 1.11 0.97 1.10 1.11 1.25**(*) 1.08 1.23**(*)
His 1.33(*) 1.50**(*) 1.25 1.33(*) 1.59 0.99 1.72 1.05 0.93 1.63(*) 1.91(*) 1.10 1.30(*) 1.15 1.17 1.26
Ile 1.36(*) 1.09 1.36(**) 1.10 0.94 0.68*(*) 1.23 1.00 1.27 0.93 1.02 1.06 1.07 1.15* 1.05 1.24*(*)
Leu 0.91 0.81*** 0.82(*) 0.96 0.84 1.03 0.86 1.18 0.87 1.07 0.82 1.14 0.76*(*) 0.87** 0.82(*) 0.86*(*)
Lys 0.73 0.83 0.63(*) 0.90 0.73(*) 0.47(*) 0.87 0.72 1.08 1.36(*) 1.08 1.42*(*)
Phe 0.94 1.03 1.02 1.03 1.03 1.10 0.78 1.15 0.71 1.02 0.68 0.82 0.85 1.19** 1.03 1.18
Pro 1.58 0.69 1.59 0.83 2.35 0.18 2.74 0.19 2.88 0.17 5.08 0.21 0.56 0.51 0.63 0.44
Ser 1.18 1.19(*) 0.88 1.70*** 0.96 1.53*(*) 0.98 1.58**(*) 1.10 0.74(*) 0.87 1.01 1.09 1.24*(*) 0.90 1.40***
Thr 1.28*(*) 1.23** 1.07 1.55*** 0.91 0.93 0.82 1.06 1.09 1.36*(*) 1.09 1.40*(*) 1.31**(*) 1.20*(*) 1.12 1.37***
Tyr 1.25 1.27** 1.30(*) 1.06 0.79 1.04 1.13 1.01 1.18 1.30 1.12 1.26
Val 0.94 0.86** 0.94 0.75*** 1.27 1.27(*) 1.24 1.53*(*) 1.01 1.07 0.77 1.21 1.05 0.96 0.91 1.03
Overall 1.13*** 1.03 1.02 1.13*** 0.95 1.03 0.93 1.15**(*) 1.06 1.08*(*) 1.06 1.15*** 1.08*(*) 1.08*** 1.00 1.19***

Note. —AA: amino acid; EA: exposed and aggregation-prone sites; BN: buried and non-aggregation-prone sites; BA: buried and aggregation-prone sites; EN: exposed and non-aggregation-prone sites; -: no optimal codon. Significance levels:

***

P < 0.001;

**

P < 0.01;

*

P < 0.05.

Significance levels in parentheses disappear after correction for multiple testing.